The proof of the effectiveness in app-based cognitive behavioural therapy for migraine - a prospective intervention study.

Hashidume Masahiro0 个研究点目标入组 60 人开始时间: 2023年2月20日最近更新: 2024年4月1日

适应症

试验速览

暂无简介。

•1) Men and women aged 18 years and over.
•2) Patients with migraine without aura or migraine with aura (International Classification of Headache, 3rd edition codes 1.1, 1.2.1.1 or 1.3) at least twice a month or on at least 4 days at the time of obtaining consent and enrolment.
•3) Patients on migraine prophylaxis medication, if not changed within 3 months.
•4) Patients whose consent to participate in this study is obtained in writing.
•5) Patients who use a smartphone on a daily basis.

•1) Patients who have started or changed migraine prophylaxis medication within the last 3 months.
•2) Patients treated with botulinum toxin or nerve blocks within the last 3 months.
•3) Patients with secondary headache, excluding drug abuse headache.
•4) Patients with severe neurological or psychiatric disorders.
•5) Patients with serious complications such as cardiac, hepatic or renal disorders.
•6) Patients who participated in any clinical trial in the 4 weeks prior to obtaining consent.
•7) Other patients who are judged by the doctor to be unsuitable for the treatment.

发起方

Hashidume Masahiro